These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
271 related items for PubMed ID: 23765045
1. Qutenza (capsaicin) 8% patch onset and duration of response and effects of multiple treatments in neuropathic pain patients. Mou J, Paillard F, Turnbull B, Trudeau J, Stoker M, Katz NP. Clin J Pain; 2014 Apr; 30(4):286-94. PubMed ID: 23765045 [Abstract] [Full Text] [Related]
2. Predictors of Response in Patients With Postherpetic Neuralgia and HIV-Associated Neuropathy Treated With the 8% Capsaicin Patch (Qutenza). Katz NP, Mou J, Paillard FC, Turnbull B, Trudeau J, Stoker M. Clin J Pain; 2015 Oct; 31(10):859-66. PubMed ID: 25503598 [Abstract] [Full Text] [Related]
3. Efficacy of Qutenza® (capsaicin) 8% patch for neuropathic pain: a meta-analysis of the Qutenza Clinical Trials Database. Mou J, Paillard F, Turnbull B, Trudeau J, Stoker M, Katz NP. Pain; 2013 Sep; 154(9):1632-1639. PubMed ID: 23707278 [Abstract] [Full Text] [Related]
4. Capsaicin 8% topical patch (Qutenza)--a review of the evidence. Jones VM, Moore KA, Peterson DM. J Pain Palliat Care Pharmacother; 2011 Sep; 25(1):32-41. PubMed ID: 21426216 [Abstract] [Full Text] [Related]
5. NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia: a randomised, double-blind study. Backonja M, Wallace MS, Blonsky ER, Cutler BJ, Malan P, Rauck R, Tobias J, NGX-4010 C116 Study Group. Lancet Neurol; 2008 Dec; 7(12):1106-12. PubMed ID: 18977178 [Abstract] [Full Text] [Related]
9. Effect of duration of postherpetic neuralgia on efficacy analyses in a multicenter, randomized, controlled study of NGX-4010, an 8% capsaicin patch evaluated for the treatment of postherpetic neuralgia. Webster LR, Tark M, Rauck R, Tobias JK, Vanhove GF. BMC Neurol; 2010 Oct 11; 10():92. PubMed ID: 20937130 [Abstract] [Full Text] [Related]
14. A multicenter, randomized, double-blind, controlled study of NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia. Irving GA, Backonja MM, Dunteman E, Blonsky ER, Vanhove GF, Lu SP, Tobias J, NGX-4010 C117 Study Group. Pain Med; 2011 Jan 11; 12(1):99-109. PubMed ID: 21087403 [Abstract] [Full Text] [Related]
19. A randomized vehicle-controlled trial of topical capsaicin in the treatment of postherpetic neuralgia. Watson CP, Tyler KL, Bickers DR, Millikan LE, Smith S, Coleman E. Clin Ther; 1993 Jan 11; 15(3):510-26. PubMed ID: 8364943 [Abstract] [Full Text] [Related]